Cite
Hohmann MS, Habiel DM, Espindola MS, et al. Antibody-mediated depletion of CCR10+EphA3+ cells ameliorates fibrosis in IPF. JCI Insight. 2021;6(11)doi: 10.1172/jci.insight.141061.
Hohmann, M. S., Habiel, D. M., Espindola, M. S., Huang, G., Jones, I., Narayanan, R., Coelho, A. L., Oldham, J. M., Noth, I., Ma, S. F., Kurkciyan, A., McQualter, J. L., Carraro, G., Stripp, B., Chen, P., Jiang, D., Noble, P. W., Parks, W., Woronicz, J., Yarranton, G., Murray, L. A., & Hogaboam, C. M. (2021). Antibody-mediated depletion of CCR10+EphA3+ cells ameliorates fibrosis in IPF. JCI insight, 6(11), . https://doi.org/10.1172/jci.insight.141061
Hohmann, Miriam S, et al. "Antibody-mediated depletion of CCR10+EphA3+ cells ameliorates fibrosis in IPF." JCI insight vol. 6,11 (2021). doi: https://doi.org/10.1172/jci.insight.141061
Hohmann MS, Habiel DM, Espindola MS, Huang G, Jones I, Narayanan R, Coelho AL, Oldham JM, Noth I, Ma SF, Kurkciyan A, McQualter JL, Carraro G, Stripp B, Chen P, Jiang D, Noble PW, Parks W, Woronicz J, Yarranton G, Murray LA, Hogaboam CM. Antibody-mediated depletion of CCR10+EphA3+ cells ameliorates fibrosis in IPF. JCI Insight. 2021 Jun 08;6(11). doi: 10.1172/jci.insight.141061. PMID: 33945505; PMCID: PMC8262321.
Copy
Download .nbib